Galaxy And Mass Assembly (GAMA): data release 4 and the z < 0.1 total and z < 0.08 morphological galaxy stellar mass functions

Galaxie

Oxide ion/electronic polarizability, optical basicity and linear dielectric susceptibility of TeO2 - B2O3 - SiO2 glasses

A system of bio-silica borotellurite glasses was fabricated based on the chemical formula [(TeO2)0.7 (B2O3)0.3]1-x (SiO2)x with x = 0.1, 0.2, 0.3, and 0.4 using the melt-quenching technique using silica (98.548% SiO2, from rice husk), TeO2 (Alfar Aeser, 99.9%) and B2O3 (Alfar Aeser, 99.9%). Measurements and characterizations such as density and molar volume measurements, XRD analysis, FTIR, and UV–Vis spectroscopes were performed on the studied glasses. The objective was to determine the glasses’ applicability in optoelectronics, non-linear optics, and laser technologies through polarizability, linear electric susceptibility, and optical basicity study. Apart from confirming the amorphous nature of the glasses, the XRD analysis identified the presence of a crystalline phase of tellurium oxide (α-TeO2) formed. The FTIR spectral study revealed the presence of TeO3, BO3, and SiO4 structural units in the studied glasses. The refractive index (2.3026 – 2.2651), molar polarizability (8.0696 – 9.4334 A3), oxide ion polarizability (3.2970 – 3.6202 A3), electronic polarizability (0.2296 – 0.2335 A3), dielectric constant (5.1307 – 5.3019), optical basicity (0.6719 – 0.7998), metallization criterion (0.410853 – 0.420714) and electric susceptibility (0.3286 – 0.3422 esu) of the glasses were presented. With the high refractive index and favourable electronic/oxide ion polarizability as well as good electric susceptibility, the glasses have shown great potential for optical fibre and laser applications. Metallization criterion value falls in the range of glasses with great potentials for non-linear optical application. The dielectric value suggests the glasses represent wideband semiconducting glasses believed to be good for application in microelectronic substrates fabrication

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Thirty two patients with active Crohn's disease were included in a controlled randomised trial to determine the efficacy and safety of polymeric enteral nutrition compared with steroids, to achieve and maintain clinical remission. The polymeric diet was administered through a fine bore nasogastric tube by continuous, pump assisted infusion (2800 (SEM 120) kcal/day). The steroid group received 1 mg/kg/day of prednisone. Both treatments were effective in inducing clinical remission: 15 of the 17 patients given steroids and 12 of the 15 patients assigned to the polymeric diet went into clinical remission (defined by a Van Hees index < 120) within four weeks of treatment. The percentage reduction of the Van Hees index was 34.8 (4.9)% for steroids and 32.3 (5)% for enteral nutrition (mean difference 2.5%; 95% CI--11.8% to +16.8%). Mean time elapsed to achieve remission was similar in both groups (2.0 (1) v 2.4 (1.2) weeks). Tolerance of the enteral diet was excellent. Four patients in the steroid group had mild complications attributable to this treatment. Ten patients (66.6%) in the steroid group and five (41.6%) in the enteral nutrition group relapsed within a year of discharge, but no differences were found in the cumulative probability of relapse during the follow up period. These results suggest that polymeric enteral nutrition is as safe and effective as steroids in inducing short term remission in active Crohn's disease